XML 19 R13.htm IDEA: XBRL DOCUMENT
v3.26.1

Balance Sheet Components | 3 Months Ended
--- | ---
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Balance Sheet Components | Note 6 — Balance Sheet Components Cash, cash equivalents, and restricted cash A reconciliation of cash, cash equivalents, and restricted cash reported in the accompanying condensed consolidated balance sheets to the amount reported within the accompanying condensed consolidated statements of cash flows was as follows (in thousands):
|  | March 31, 2026 |  |  | December 31, 2025 |
Cash and cash equivalents |  | $ | 129,843 |  |  | $ | 122,518 |
Restricted cash |  |  | 3,111 |  |  |  | 3,114 |
Total cash, cash equivalents, and restricted cash as reported within our condensed consolidated statement of cash flows |  | $ | 132,954 |  |  | $ | 125,632 |
As of March 31, 2026, our restricted cash balance of $3.1 million is used to collateralize certain credit instruments. Accounts receivable, net Accounts receivable, net was as follows (in thousands):
|  | March 31, 2026 |  |  | December 31, 2025 |
Accounts receivable, net: |  |  |  |  |  |
Net product receivables |  | $ | 4,473 |  |  | $ | — |
Collaboration receivables |  |  | 2,354 |  |  |  | 17,764 |
Total accounts receivable, net |  | $ | 6,827 |  |  | $ | 17,764 |
Inventories Inventories were as follows (in thousands):
|  | March 31, 2026 |  |  | December 31, 2025 |
Inventories: |  |  |  |  |  |
Finished goods |  | $ | 154 |  |  | $ | — |
Total inventories, current |  |  | 154 |  |  |  | — |
Inventories, long-term (1) |  |  | 3,843 |  |  |  | — |
Total current and long-term inventories |  | $ | 3,997 |  |  | $ | — |
(1) Inventories, long-term, are comprised of raw materials and work in process that are expected to be sold beyond the next 12 months. Accrued liabilities Accrued liabilities were as follows (in thousands):
|  | March 31, 2026 |  |  | December 31, 2025 |
Accrued liabilities: |  |  |  |  |  |
Clinical and preclinical costs |  | $ | 23,981 |  |  | $ | 24,561 |
Compensation related |  |  | 27,355 |  |  |  | 45,150 |
Other accrued expenses |  |  | 17,527 |  |  |  | 13,567 |
Total accrued liabilities |  | $ | 68,863 |  |  | $ | 83,278 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration